The largestbiopsy study conducted to date demonstrates that a lower dose of an inhaledcorticosteroid (ICS) with the addition of a long acting beta2-agonist(LABA) is as effective in maintaining control of airway inflammation as amedium-dose ICS alone in patients with moderate asthma. [click link for full article]
(more...)